Clinical impact of first‐line PD‐1 or PD‐L1 inhibitors combined with chemotherapy in extensive‐stage small cell lung cancer patients: A real‐world multicenter propensity score‐matched study

OBJECTIVES: Our research aimed to evaluate the effectiveness of first‐line immune checkpoint inhibitors (ICIs) with etoposide and platinum (EP) for extensive‐stage small cell lung cancer (ES‐SCLC) and identify prognostic factors, as real‐world outcomes and the inconsistency of PD‐1 and PD‐L1 inhibit...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Jingyuan, Chen, Mo, Han, Hedong, Xu, Ke, Qiu, Guihuan, Lin, Xinqing, Song, Yong, Ye, Jinjun, Lv, Tangfeng, Zhan, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10212658/
https://www.ncbi.nlm.nih.gov/pubmed/37005095
http://dx.doi.org/10.1111/1759-7714.14874

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10212658/
https://www.ncbi.nlm.nih.gov/pubmed/37005095
http://dx.doi.org/10.1111/1759-7714.14874

Ejemplares similares